BPHA

BPHA
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T36712-1mg 1 mg -

7 - 10 business days*

210.00€
TGM-T36712-5mg 5 mg -

7 - 10 business days*

581.00€
TGM-T36712-1mL 1 ml -

7 - 10 business days*

598.00€
TGM-T36712-10mg 10 mg -

7 - 10 business days*

831.00€
TGM-T36712-25mg 25 mg -

7 - 10 business days*

1,265.00€
TGM-T36712-50mg 50 mg -

7 - 10 business days*

1,697.00€
TGM-T36712-100mg 100 mg -

7 - 10 business days*

2,286.00€
TGM-T36712-500mg 500 mg -

7 - 10 business days*

4,604.00€
 
Description: BPHA (MMP-2/MMP-9 Inhibitor II) is a potent, selective and orally active inhibitor... more
Product information "BPHA"
Description: BPHA (MMP-2/MMP-9 Inhibitor II) is a potent, selective and orally active inhibitor of MMP-2, MMP-9 and MMP-14 with IC50s of 12 nM, 16 nM and 17 nM, respectively.BPHA does not inhibit MMP-1, -3 and -7 (IC50s of 974, >1000 and 795 nM, respectively).BPHA has anti-angiogenic and BPHA has anti-angiogenic and anti-tumor activities. Target: MMP. Smiles: S(N[C@H](CC1=CC=CC=C1)C(NO)=O)(=O)(=O)C2=CC=C(C=C2)C3=CC=CC=C3. References: Maekawa R, et al. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res. 1999,59(6):1231-1235.
Keywords: MMP-2/MMP-9 Inhibitor II
Supplier: TargetMol
Supplier-Nr: T36712

Properties

Application: MMP2 / MMP9 inhibitor
MW: 396.46 D
Formula: C21H20N2O4S

Database Information

CAS : 193807-60-2| Matching products
KEGG ID : K01398 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "BPHA"
Write a review
or to review a product.
Viewed